; (2) is a sterile injectable drug; and (3) is vulnerable to shortage, including as determined through notifications submitted to the Secretary under section 506C. (c) Grant selection As a condition for accepting a grant under this section, an institution of higher education and nonprofit entity shall agree to develop and carrying out a robust plan focused on sustainability of the continuous manufacturing or other advanced manufacturing capabilities supported by the grant. (d) Authorization of appropriations To carry out this section, in additional to amounts otherwise made available for such purposes, there is authorized to be appropriated $1,000,000,000 for the period of fiscal years 2024 through 2029. (e) Definitions In this section: (1) Advanced manufacturing The term advanced manufacturing means an approach for the manufacturing of drugs that incorporates novel technology, or uses an established technique or technology in a new or innovative that enhances drug quality or improves the manufacturing process. (2) Continuous manufacturing The term continuous manufacturing — (A) means a process where the input materials are continuously fed into and transformed within the process, and the processed output materials are continuously removed from the system